Global Biologics and Biosimilars Competitive Landscape Professional Research Report 2024

Research Summary

Biologics are pharmaceutical drugs derived from living organisms, such as proteins, antibodies, or nucleic acids. They are produced using biotechnology processes and are used for the treatment of various diseases, including cancer, autoimmune disorders, and genetic diseases. Biologics are often highly complex and require specialized manufacturing techniques to ensure their safety, efficacy, and consistency. Biosimilars, on the other hand, are biological products that are highly similar to an already approved reference biologic. They are developed to have comparable efficacy, safety, and quality to the reference product and undergo rigorous testing to demonstrate similarity. Biosimilars offer a more affordable alternative to the original biologic, providing increased access to life-saving therapies. They are regulated by health authorities to ensure their quality, efficacy, and safety. Biologics and biosimilars have revolutionized the field of medicine, offering innovative and effective treatment options for patients with various medical conditions.

According to DIResearch's in-depth investigation and research, the global Biologics and Biosimilars market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.

The major global manufacturers of Biologics and Biosimilars include Roche, Amgen, AbbVie, Sanofi, Johnson & Johnson, Pfizer, Novo Nordisk, Eli Lilly, Novartis, Merck, Biogen, Celltrion, Sobi, 3SBIO, Changchun High Tech, Kanghong Pharma, Innovent Biologics, Gan&Lee, Tonghua Dongbao, United Laboratory etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.

This report studies the market size, price trends and future development prospects of Biologics and Biosimilars. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Biologics and Biosimilars market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Biologics and Biosimilars market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Biologics and Biosimilars industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Biologics and Biosimilars Include:

Roche

Amgen

AbbVie

Sanofi

Johnson & Johnson

Pfizer

Novo Nordisk

Eli Lilly

Novartis

Merck

Biogen

Celltrion

Sobi

3SBIO

Changchun High Tech

Kanghong Pharma

Innovent Biologics

Gan&Lee

Tonghua Dongbao

United Laboratory

Biologics and Biosimilars Product Segment Include:

Monoclonal Antibodies

Interferon

Insulin

Vaccines

Others

Biologics and Biosimilars Product Application Include:

Hospital

Retail Pharmacy

Other

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Biologics and Biosimilars Industry PESTEL Analysis

Chapter 3: Global Biologics and Biosimilars Industry Porter's Five Forces Analysis

Chapter 4: Global Biologics and Biosimilars Major Regional Market Size and Forecast Analysis

Chapter 5: Global Biologics and Biosimilars Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Biologics and Biosimilars Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Biologics and Biosimilars Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Biologics and Biosimilars Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Biologics and Biosimilars Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Biologics and Biosimilars Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Biologics and Biosimilars Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Biologics and Biosimilars Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources

Table of Contents

1 Biologics and Biosimilars Market Overview

1.1 Product Definition and Statistical Scope

1.2 Biologics and Biosimilars Product by Type

1.2.1 Global Biologics and Biosimilars Market Size by Type, 2023 VS 2024 VS 2030

1.2.2 Monoclonal Antibodies

1.2.3 Interferon

1.2.4 Insulin

1.2.5 Vaccines

1.2.6 Others

1.3 Biologics and Biosimilars Product by Application

1.3.1 Global Biologics and Biosimilars Market Size by Application, 2023 VS 2024 VS 2030

1.3.2 Hospital

1.3.3 Retail Pharmacy

1.3.4 Other

1.4 Global Biologics and Biosimilars Market Revenue Analysis (2019-2030)

1.5 Biologics and Biosimilars Market Development Status and Trends

1.5.1 Biologics and Biosimilars Industry Development Status Analysis

1.5.2 Biologics and Biosimilars Industry Development Trends Analysis

2 Biologics and Biosimilars Market PESTEL Analysis

2.1 Political Factors Analysis

2.2 Economic Factors Analysis

2.3 Social Factors Analysis

2.4 Technological Factors Analysis

2.5 Environmental Factors Analysis

2.6 Legal Factors Analysis

3 Biologics and Biosimilars Market Porter's Five Forces Analysis

3.1 Competitive Rivalry

3.2 Threat of New Entrants

3.3 Bargaining Power of Suppliers

3.4 Bargaining Power of Buyers

3.5 Threat of Substitutes

4 Global Biologics and Biosimilars Market Analysis by Regions

4.1 Biologics and Biosimilars Overall Market: 2023 VS 2024 VS 2030

4.2 Global Biologics and Biosimilars Revenue and Forecast Analysis (2019-2030)

4.2.1 Global Biologics and Biosimilars Revenue and Market Share by Region (2019-2024)

4.2.2 Global Biologics and Biosimilars Revenue Forecast by Region (2025-2030)

5 Global Biologics and Biosimilars Market Size by Type and Application

5.1 Global Biologics and Biosimilars Market Size by Type

5.2 Global Biologics and Biosimilars Market Size by Application

6 North America

6.1 North America Biologics and Biosimilars Market Size and Growth Rate Analysis (2019-2030)

6.2 North America Key Manufacturers Analysis

6.3 North America Biologics and Biosimilars Market Size by Type

6.4 North America Biologics and Biosimilars Market Size by Application

6.5 North America Biologics and Biosimilars Market Size by Country

6.5.1 US

6.5.2 Canada

7 Europe

7.1 Europe Biologics and Biosimilars Market Size and Growth Rate Analysis (2019-2030)

7.2 Europe Key Manufacturers Analysis

7.3 Europe Biologics and Biosimilars Market Size by Type

7.4 Europe Biologics and Biosimilars Market Size by Application

7.5 Europe Biologics and Biosimilars Market Size by Country

7.5.1 Germany

7.5.2 France

7.5.3 United Kingdom

7.5.4 Italy

7.5.5 Spain

7.5.6 Benelux

8 China

8.1 China Biologics and Biosimilars Market Size and Growth Rate Analysis (2019-2030)

8.2 China Key Manufacturers Analysis

8.3 China Biologics and Biosimilars Market Size by Type

8.4 China Biologics and Biosimilars Market Size by Application

9 APAC (excl. China)

9.1 APAC (excl. China) Biologics and Biosimilars Market Size and Growth Rate Analysis (2019-2030)

9.2 APAC (excl. China) Key Manufacturers Analysis

9.3 APAC (excl. China) Biologics and Biosimilars Market Size by Type

9.4 APAC (excl. China) Biologics and Biosimilars Market Size by Application

9.5 APAC (excl. China) Biologics and Biosimilars Market Size by Country

9.5.1 Japan

9.5.2 South Korea

9.5.3 India

9.5.4 Australia

9.5.5 Indonesia

9.5.6 Vietnam

9.5.7 Malaysia

9.5.8 Thailand

10 Latin America

10.1 Latin America Biologics and Biosimilars Market Size and Growth Rate Analysis (2019-2030)

10.2 Latin America Key Manufacturers Analysis

10.3 Latin America Biologics and Biosimilars Market Size by Type

10.4 Latin America Biologics and Biosimilars Market Size by Application

10.5 Latin America Biologics and Biosimilars Market Size by Country

10.5.1 Mecixo

10.5.2 Brazil

11 Middle East & Africa

11.1 Middle East & Africa Biologics and Biosimilars Market Size and Growth Rate Analysis (2019-2030)

11.2 Middle East & Africa Key Manufacturers Analysis

11.3 Middle East & Africa Biologics and Biosimilars Market Size by Type

11.4 Middle East & Africa Biologics and Biosimilars Market Size by Application

11.5 Middle East & Africa Biologics and Biosimilars Market Size by Country

11.5.1 Saudi Arabia

11.5.2 South Africa

12 Market Competition by Manufacturers

12.1 Global Biologics and Biosimilars Market Revenue by Key Manufacturers (2020-2024)

12.2 Biologics and Biosimilars Competitive Landscape Analysis and Market Dynamic

12.2.1 Biologics and Biosimilars Competitive Landscape Analysis

12.2.2 Global Key Manufacturers Headquarter and Key Area Sales

12.2.3 Market Dynamic

13 Key Companies Analysis

13.1 Roche

13.1.1 Roche Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.1.2 Roche Biologics and Biosimilars Product Portfolio

13.1.3 Roche Biologics and Biosimilars Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.2 Amgen

13.2.1 Amgen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.2.2 Amgen Biologics and Biosimilars Product Portfolio

13.2.3 Amgen Biologics and Biosimilars Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.3 AbbVie

13.3.1 AbbVie Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.3.2 AbbVie Biologics and Biosimilars Product Portfolio

13.3.3 AbbVie Biologics and Biosimilars Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.4 Sanofi

13.4.1 Sanofi Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.4.2 Sanofi Biologics and Biosimilars Product Portfolio

13.4.3 Sanofi Biologics and Biosimilars Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.5 Johnson & Johnson

13.5.1 Johnson & Johnson Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.5.2 Johnson & Johnson Biologics and Biosimilars Product Portfolio

13.5.3 Johnson & Johnson Biologics and Biosimilars Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.6 Pfizer

13.6.1 Pfizer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.6.2 Pfizer Biologics and Biosimilars Product Portfolio

13.6.3 Pfizer Biologics and Biosimilars Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.7 Novo Nordisk

13.7.1 Novo Nordisk Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.7.2 Novo Nordisk Biologics and Biosimilars Product Portfolio

13.7.3 Novo Nordisk Biologics and Biosimilars Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.8 Eli Lilly

13.8.1 Eli Lilly Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.8.2 Eli Lilly Biologics and Biosimilars Product Portfolio

13.8.3 Eli Lilly Biologics and Biosimilars Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.9 Novartis

13.9.1 Novartis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.9.2 Novartis Biologics and Biosimilars Product Portfolio

13.9.3 Novartis Biologics and Biosimilars Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.10 Merck

13.10.1 Merck Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.10.2 Merck Biologics and Biosimilars Product Portfolio

13.10.3 Merck Biologics and Biosimilars Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.11 Biogen

13.11.1 Biogen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.11.2 Biogen Biologics and Biosimilars Product Portfolio

13.11.3 Biogen Biologics and Biosimilars Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.12 Celltrion

13.12.1 Celltrion Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.12.2 Celltrion Biologics and Biosimilars Product Portfolio

13.12.3 Celltrion Biologics and Biosimilars Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.13 Sobi

13.13.1 Sobi Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.13.2 Sobi Biologics and Biosimilars Product Portfolio

13.13.3 Sobi Biologics and Biosimilars Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.14 3SBIO

13.14.1 3SBIO Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.14.2 3SBIO Biologics and Biosimilars Product Portfolio

13.14.3 3SBIO Biologics and Biosimilars Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.15 Changchun High Tech

13.15.1 Changchun High Tech Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.15.2 Changchun High Tech Biologics and Biosimilars Product Portfolio

13.15.3 Changchun High Tech Biologics and Biosimilars Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.16 Kanghong Pharma

13.16.1 Kanghong Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.16.2 Kanghong Pharma Biologics and Biosimilars Product Portfolio

13.16.3 Kanghong Pharma Biologics and Biosimilars Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.17 Innovent Biologics

13.17.1 Innovent Biologics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.17.2 Innovent Biologics Biologics and Biosimilars Product Portfolio

13.17.3 Innovent Biologics Biologics and Biosimilars Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.18 Gan&Lee

13.18.1 Gan&Lee Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.18.2 Gan&Lee Biologics and Biosimilars Product Portfolio

13.18.3 Gan&Lee Biologics and Biosimilars Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.19 Tonghua Dongbao

13.19.1 Tonghua Dongbao Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.19.2 Tonghua Dongbao Biologics and Biosimilars Product Portfolio

13.19.3 Tonghua Dongbao Biologics and Biosimilars Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.20 United Laboratory

13.20.1 United Laboratory Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.20.2 United Laboratory Biologics and Biosimilars Product Portfolio

13.20.3 United Laboratory Biologics and Biosimilars Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

14 Industry Chain Analysis

14.1 Biologics and Biosimilars Industry Chain Analysis

14.2 Biologics and Biosimilars Industry Raw Material and Suppliers Analysis

14.2.1 Upstream Key Raw Material Supply Analysis

14.2.2 Raw Material Suppliers and Contact Information

14.3 Biologics and Biosimilars Typical Downstream Customers

14.4 Biologics and Biosimilars Sales Channel Analysis

15 Research Findings and Conclusion

16 Methodology and Data Source

16.1 Methodology/Research Approach

16.2 Research Scope

16.3 Benchmarks and Assumptions

16.4 Date Source

16.4.1 Primary Sources

16.4.2 Secondary Sources

16.5 Data Cross Validation

16.6 Disclaimer

Name*

Email ID*

Company*

Phone (With Country Code)*

What is/are your question(s)?:

Publisher: DIResearch

Related Reports

Global Epilepsy Therapeutics Market (2024 Edition): Analysis By Generation (First Generation, Second Generation, Third Generation), By Route of Administration, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)

Global Online Pharmacy Market (2024 Edition): Analysis By Drug Type (Over the Counter (OTC) Drugs, Prescription Drugs, Others), By Platform, By Product Type, By Region: Market Insights and Forecast (2020-2030)

Global Diagnostic X-rays Market (2024 Edition): Analysis By Type (General Radiography, Angiography, Surgical Fluoroscopy, Mobile X ray, Other Types), By End Users, By Region, By Country: Market Insights and Forecast (2020-2030)

Global Diagnostic Labs Market (2024 Edition): Analysis By Testing Services (Physiological Function Testing, General and Clinical Testing, Esoteric Testing, Specialized Testing, and Others), By Lab Type, By Application: Market Insights and Forecast (2020-2030)

Lateral Flow Assays Market By Product Type (Lateral Flow Readers {Digital/Mobile Readers and Benchtop Readers} and Kits and Reagents), By Application (Clinical Testing {Pregnancy Testing, Influenza Testing, Tuberculosis, D-Dimer Testing, and Other Clinical Testing}, Drug Abuse Testing, Veterinary Diagnostics, Food Safety & Environmental Testing, and Other Applications), By Technique (Sandwich Assay, Competitive Assay, and Multiplex Assay), By End-User (Home Care, Hospitals and Clinics, and Other End Users), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035

Why Market Study Report?

Best Price for Reports
Large Report Database
Easily Customize Reports
24/7 Email & Phone Support